Maxim Group analyst Jason McCarthy downgrades Aridis Pharmaceuticals (NASDAQ:ARDS) from Buy to Hold.
Centrus Energy Q4 EPS $1.42 Beats $0.82 Estimate, Sales $126.20M Beat $89.95M Estimate
Centrus Energy (AMEX:LEU) reported quarterly earnings of $1.42 per share which beat the analyst consensus estimate of $0.82 by 73.17 percent. This is a 82.56 percent decrease over earnings of $8.14 per share from the
